Impact of Medicaid Restrictions on Availability of Buprenorphine in Addiction Treatment Programs

Objectives. To examine how utilization restrictions on state Medicaid benefits for buprenorphine are related to addiction treatment programs’ decision to offer the drug. Methods. We used data from 2 waves of the National Drug Abuse Treatment System Survey conducted in 2014 and 2017 in the United Sta...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Public Health
Egile Nagusiak: Andrews, Christina M., Abraham, Amanda J., Grogan, Colleen M., Westlake, Melissa A., Pollack, Harold A., Friedmann, Peter D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Public Health Association 2019
Gaiak:
AJPH Policy
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6366513/
https://ncbi.nlm.nih.gov/pubmed/30676789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2105/AJPH.2018.304856
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak